European Journal of Heart Failure, 1879-0844

Journal

More filtering options
  1. 2020
  2. Viral genome search in myocardium of patients with fulminant myocarditis

    Giacomo Veronese, Enrico Ammirati, Michela Brambatti, Marco Merlo, Manlio Cipriani, Luciano Potena, Paola Sormani, Tatsuo Aoki, Koichiro Sugimura, Akinori Sawamura, Takahiro Okumura, Sean Pinney, Kimberly Hong, Palak Shah, Oscar Braun, Caroline M. Van de Heyning, Santiago Montero, Duccio Petrella, Florent Huang, Matthieu Schmidt & 26 others, Claudia Raineri, Anuradha Lala, Marisa Varrenti, Alberto Foà, Ornella Leone, Piero Gentile, Jessica Artico, Valentina Agostini, Rajiv Patel, Andrea Garascia, Emeline M. Van Craenenbroeck, Kaoru Hirose, Akihiro Isotani, Toyoaki Murohara, Yoh Arita, Alessandro Sionis, Enrico Fabris, Sherin Hashem, Victor Garcia-Hernando, Fabrizio Oliva, Barry Greenberg, Hiroaki Shimokawa, Gianfranco Sinagra, Eric D. Adler, Maria Frigerio & Paolo G. Camici, 2020 Jul, In: European Journal of Heart Failure. 22, 7, p. 1277-1280 4 p.

    Research output: Contribution to journalLetter

  3. Improving risk prediction in heart failure using machine learning

    Eric D. Adler, Adriaan A. Voors, Liviu Klein, Fima Macheret, Oscar O. Braun, Marcus A. Urey, Wenhong Zhu, Iziah Sama, Matevz Tadel, Claudio Campagnari, Barry Greenberg & Avi Yagil, 2020 Jan, In: European Journal of Heart Failure. 22, 1, p. 139-147 9 p.

    Research output: Contribution to journalArticle

  4. 2019
  5. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure

    Piotr Ponikowski, Bridget Anne Kirwan, Stefan D. Anker, Maria Dorobantu, Jarosław Drozdz, Vincent Fabien, Gerasimos Filippatos, Teba Haboubi, Andre Keren, Irakli Khintibidze, Hans Kragten, Felipe A. Martinez, Theresa McDonagh, Marco Metra, Davor Milicic, José C. Nicolau, Marcus Ohlsson, Alexander Parhomenko, Domingo A. Pascual-Figal, Frank Ruschitzka & 4 others, David Sim, Hadi Skouri, Peter van der Meer & Ewa A. Jankowska, 2019, In: European Journal of Heart Failure. 21, 12, p. 1651-1658 8 p.

    Research output: Contribution to journalArticle

  6. 2015
  7. The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study

    Piotr Ponikowski, Gerasimos Filippatos, Josep Comin Colet, Ronnie Willenheimer, Kenneth Dickstein, Thomas Luescher, Giedrius Gaudesius, Barbara von Eisenhart Rothe, Claudio Mori, Nicola Greenlaw, Ian Ford, Iain Macdougall & Stefan D. Anker, 2015, In: European Journal of Heart Failure. 17, 3, p. 329-339

    Research output: Contribution to journalArticle

  8. 2014
  9. A risk score for predicting 30-day mortality in heart failure patients undergoing non-cardiac surgery

    Charlotte Andersson, Gunnar H. Gislason, Mark Hlatky, Kathrine Bach Sondergaard, Jannik Pallisgaard, Gustav Smith, Ramachandran S. Vasan, Martin G. Larson, Per Foge Jensen, Lars Kober & Christian Torp-Pedersen, 2014, In: European Journal of Heart Failure. 16, 12, p. 1310-1316

    Research output: Contribution to journalArticle

  10. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members

    Jorg Saberniak, Nina E. Hasselberg, Rasmus Borgquist, Pyotr Platonov, Sebastian I. Sarvari, Hans-Jorgen Smith, Margareth Ribe, Anders G. Holst, Thor Edvardsen & Kristina H. Haugaa, 2014, In: European Journal of Heart Failure. 16, 12, p. 1337-1344

    Research output: Contribution to journalArticle

  11. 2013
  12. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

    Gerasimos Filippatos, Dimitrios Farmakis, Josep Comin Colet, Kenneth Dickstein, Thomas F. Luescher, Ronnie Willenheimer, John Parissis, Giedrius Gaudesius, Claudio Mori, Barbara von Eisenhart Rothe, Nicola Greenlaw, Ian Ford, Piotr Ponikowski & Stefan D. Anker, 2013, In: European Journal of Heart Failure. 15, 11, p. 1267-1276

    Research output: Contribution to journalArticle

  13. Three decades of heart transplantation in Scandinavia: long-term follow-up

    Goran Dellgren, Odd Geiran, Karl Lemstrom, Finn Gustafsson, Hans Eiskjaer, Bansi Koul, Inger Hagerman & Nedim Selimovic, 2013, In: European Journal of Heart Failure. 15, 3, p. 308-315

    Research output: Contribution to journalArticle

  14. 2011
  15. Depression and health-related quality of life in elderly patients suffering from heart failure and their spouses: a comparative study

    E Pihl, A Jacobsson, Bengt Fridlund, A Stromberg & J Martensson, 2011, In: European Journal of Heart Failure. 7, 4, p. 583-589

    Research output: Contribution to journalArticle

  16. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial

    Christian Funck-Brentano, Dirk J. van Veldhuisen, Louis L. M. van de Ven, Ferenc Follath, Michael Goulder & Ronnie Willenheimer, 2011, In: European Journal of Heart Failure. 13, 7, p. 765-772

    Research output: Contribution to journalArticle

  17. 2009
  18. Rationale and design of Ferinject((R)) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

    Stefan D. Anker, Josep Comin Colet, Gerasimos Filippatos, Ronnie Willenheimer, Kenneth Dickstein, Helmut Drexler, Thomas F. Luescher, Claudio Mori, Barbara von Eisenhart Rothe, Stuart Pocock, Philip A. Poole-Wilson & Piotr Ponikowski, 2009, In: European Journal of Heart Failure. 11, 11, p. 1084-1091

    Research output: Contribution to journalArticle

  19. 2008
  20. A randomised trial of a pre-synaptic stimulator of DA(2)-dopaminergic and alpha(2)-adrenergic receptors on morbidity and mortality in patients with heart failure

    Christian Torp-Pedersen, Lars Kober, Jan E. Carlsen, Dilek Akkan, Niels E. Bruun, Dimitri Dacoronias, Kenneth Dickstein, Torben Haghfelt, Hans Öhlin & John J. V. McMurray, 2008, In: European Journal of Heart Failure. 10, 1, p. 89-95

    Research output: Contribution to journalArticle

  21. Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey.

    Leif RW Erhardt, Michel Komajda, F D Richard Hobbs & Jordi Soler-Soler, 2008, In: European Journal of Heart Failure. 10, p. 1020-1025

    Research output: Contribution to journalArticle

  22. Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg.

    Tord Juhlin, Bo A G Jönsson & Peter Höglund, 2008, In: European Journal of Heart Failure. 10, 9, p. 892-898

    Research output: Contribution to journalArticle

  23. 2007
  24. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure

    Willem J. Remme, John G. Cleland, Leif RW Erhardt, Phillip Spark, Christian Torp-Pedersen, Marco Metra, Michel Komajda, Christine Moullet, Mary Ann Lukas, Philip Poole-Wilson, Andrea Di Lenarda & Karl Swedberg, 2007, In: European Journal of Heart Failure. 9, 11, p. 1128-1135

    Research output: Contribution to journalArticle

  25. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery

    Hans Liden, Kristjan Karason, Claes-Hakan Bergh, Folke Nilsson, Bansi Koul & Lars Wiklund, 2007, In: European Journal of Heart Failure. 9, 5, p. 525-530

    Research output: Contribution to journalArticle

  26. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.

    Tord Juhlin, Leif RW Erhardt, Helene Ottosson, Bo A Jönsson & Peter Höglund, 2007, In: European Journal of Heart Failure. 9, 2, p. 191-196

    Research output: Contribution to journalArticle

  27. 2006
  28. Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".

    Ronnie Willenheimer, Henry Krum, Dirk J van Veldhuisen, Christian Funck-Brentano, Erland Erdmann & Wilfried R Meyer, 2006, In: European Journal of Heart Failure. 8, 2, p. 219-220

    Research output: Contribution to journalLetter

  29. 2005
  30. Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors.

    Tord Juhlin, Sven Bjorkman & Peter Höglund, 2005, In: European Journal of Heart Failure. 7, 6, p. 1049-1056

    Research output: Contribution to journalArticle

  31. Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression

    J Martensson, A Stromberg, U Dahlstrom, JE Karlsson & Bengt Fridlund, 2005, In: European Journal of Heart Failure. 7, 3, p. 393-403

    Research output: Contribution to journalArticle

  32. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice

    J McMurray, A Cohen-Solal, R Dietz, E Eichhorn, Leif RW Erhardt, FDR Hobbs, H Krum, A Maggioni, RS McKelvie, IL Pina, J Soler-Soler & K Swedberg, 2005, In: European Journal of Heart Failure. 7, 5, p. 710-721

    Research output: Contribution to journalArticle

Previous 1 2 Next